CervoMed Ends $20 Million Stock Sales Agreement with BTIG

The latest update is out from CervoMed ( (CRVO) ).

CervoMed Inc. had an agreement in place to sell up to $20 million of its common stock through BTIG, LLC, under a Sales Agreement that allowed for “at-the-market” offerings. However, the company decided to terminate this agreement without incurring any penalties or selling any shares under this arrangement. The termination will take effect on October 11, 2024.

For detailed information about CRVO stock, go to TipRanks’ Stock Analysis page.